Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center

OBJECTIVE: CD200 and BCL2 overexpression is independently associated with inferior survival in acute myeloid leukemia (AML), and these two factors are frequently co-expressed; however, no data are available on the role of concomitant aberrant CD200 and BCL2 expression on outcome of AML patients. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiribelli, Mario, Michelutti, Angela, Cavallin, Margherita, Di Giusto, Sara, Fanin, Renato, Damiani, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171206/
https://www.ncbi.nlm.nih.gov/pubmed/33596632
http://dx.doi.org/10.4274/tjh.galenos.2021.2020.0728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171206/
https://www.ncbi.nlm.nih.gov/pubmed/33596632
http://dx.doi.org/10.4274/tjh.galenos.2021.2020.0728

Ejemplares similares